Personalized vaccines are currently being investigated for the treatment of patients with kidney cancer; however, the investigation is still in early stages.
Dr. David A. Braun
Advertisement
Dr. David A. Braun is an Assistant Professor of Medicine (Medical Oncology) and a Louis Goodman and Alfred Gilman Yale Scholar, at Yale School of Medicine, and a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center, New Haven, Connecticut.
Articles by Dr. David A. Braun
Personalized cancer vaccines may potentially represent a step forward in guiding the immune system to more precisely target kidney cancer.
Dr. David A Braun delved into detail on the molecular factors driving exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.
Advertisement
Latest Updated Articles
An Expert Expands on What Drives ‘Exceptional’ Responses to RCC TreatmentPublished: January 22nd 2025 | Updated:
